Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-20

Clinical Trial Update: Nutritional and Neurotransmitter Changes in PKU Subjects on BH4

View source ↗

Summary

A completed Emory University clinical trial studied nutritional and neurotransmitter changes in people with phenylketonuria treated with tetrahydrobiopterin (BH…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: Emory University | Conditions: Phenylketonuria | Status: COMPLETED | Results posted: 2014-08-20